Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | DGKA | P23743 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL421809 | 0.94 | LMNA (0.41) | TSHRALDH1A1LMNAKMT2AMAPT | |
| SCHEMBL2141070 | 0.92 | LMNA (0.45) | TSHRALDH1A1LMNAKMT2AMAPT | |
| SCHEMBL21065429 | 0.92 | LMNA (0.45) | TSHRALDH1A1LMNAKMT2AMAPT | |
| SCHEMBL821271 | 0.92 | LMNA (0.45) | TSHRALDH1A1LMNAKMT2AMAPT | |
| SCHEMBL6937280 | 0.92 | LMNA (0.45) | TSHRALDH1A1LMNAKMT2AMAPT | |
| SCHEMBL8333539 | 0.92 | LMNA (0.45) | TSHRALDH1A1LMNAKMT2AMAPT | |
| SCHEMBL9621244 | 0.92 | LMNA (0.45) | TSHRALDH1A1LMNAKMT2AMAPT | |
| SCHEMBL17335504 | 0.92 | LMNA (0.45) | TSHRALDH1A1LMNAKMT2AMAPT | |
| SCHEMBL28377777 | 0.92 | LMNA (0.45) | TSHRALDH1A1LMNAKMT2AMAPT | |
| SCHEMBL5045326 | 0.90 | TSHR (0.54) | TSHRALDH1A1LMNAKMT2ASLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117417796-A | Degreasing cleaning agent and application thereof | 南京诚志清洁能源有限公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-117417796-A | Degreasing cleaning agent and application thereof | 南京诚志清洁能源有限公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-116916913-A | Pharmaceutically acceptable salts of xylometacin and use thereof | 艾留西斯治疗美国公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-115584334-B | Enterococcus faecium and application thereof in acidification and odor solving of soybean whey wastewater | 山东绿邦生物科技有限公司 | 2023-06-09 | — | — | CN | disclosed |
| US-11390890-B2 | Dibasic organic acid producing strain and preparation and application of same | TIANJIN INSTITUTE OF INDUSTRIAL BIOTECHNOLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2022-07-19 | — | — | US | disclosed |
| CN-114206445-A | Different forms of 6-chloro-2-ethyl-N- (4- (4- (4- (trifluoromethoxy) phenyl) piperidin-1-yl) benzyl) imidazo [1,2-a ] pyridine-3-carboxamide | 奎利恩特有限公司 | 2022-03-18 | — | — | CN | disclosed |
| CN-112138138-A | A pharmaceutical composition for treating gout and preparation method thereof | 乐康珍泰（天津）生物技术有限公司 | 2020-12-29 | — | — | CN | disclosed |
| US-20200347415-A1 | DIBASIC ORGANIC ACID PRODUCING STRAIN AND PREPARATION AND APPLICATION OF SAME | TIANJIN INST IND BIOTECHNOLOGY CAS (CN) | 2020-11-05 | — | — | US | disclosed |
| US-10781462-B2 | Dibasic organic acid producing strain and preparation and application of same | TIANJIN INSTITUTE OF INDUSTRIAL BIOTECHNOLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2020-09-22 | — | — | US | disclosed |
| CN-111154691-A | Variovorax capable of degrading chitin and application thereof | 中国科学院成都生物研究所 | 2020-05-15 | — | — | CN | disclosed |
| US-20150361467-A1 | METHODS, REAGENTS AND CELLS FOR BIOSYNTHESIZING COMPOUNDS | INV NYLON CHEMICALS AMERICAS, LLC | 2015-12-17 | — | — | US | disclosed |
| US-20150361464-A1 | METHODS, REAGENTS AND CELLS FOR BIOSYNTHESIZING COMPOUNDS | INVISTA NORTH AMERICA S.A.R.L. | 2015-12-17 | — | — | US | disclosed |
| CN-101407543-A | Labelled glutamine and lysine analogues | NYCOMED AMERSHAM PLC (GB) | 2009-04-15 | — | — | CN | disclosed |
| EP-0699068-B1 | REDUCTION OF LIPOSOME-INDUCED ADVERSE PHYSIOLOGICAL REACTIONS | LIPOSOME CO INC (US) | 2001-12-19 | — | — | EP | disclosed |
| CN-1309661-A | Labelled glutamine and lysine analogues | NYCOMED AMERSHAM PLC (GB) | 2001-08-22 | — | — | CN | disclosed |
| EP-1118326-A2 | Reduction of liposome-induced adverse physiological reactions | THE LIPOSOME COMPANY, INC. (US) | 2001-07-25 | — | — | EP | disclosed |
| EP-0699068-A1 | REDUCTION OF LIPOSOME-INDUCED ADVERSE PHYSIOLOGICAL REACTIONS | THE LIPOSOME COMPANY, INC. (US) | 1996-03-06 | — | — | EP | disclosed |
| WO-1994027580-A1 | REDUCTION OF LIPOSOME-INDUCED ADVERSE PHYSIOLOGICAL REACTIONS | THE LIPOSOME COMPANY, INC. (US) | 1994-12-08 | — | — | WO | disclosed |
| US-5208258-A | Antihypercholesterolemic compounds and synthesis thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1993-05-04 | — | — | US | disclosed |
| US-4950775-A | REACTING ALDEHYDE WITH KETOPHOSPHONATE SYNTHON | UNIVERSITY OF CALIFORNIA (US) | 1990-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361467-A1 | METHODS, REAGENTS AND CELLS FOR BIOSYNTHESIZING COMPOUNDS | SHMT1, ACADM, ACAT2 | TSHR 2971/4885ALDH1A1 234/4885LMNA 3618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.